Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1996-12-3
|
pubmed:abstractText |
The human MAGE-1, MAGE-3 and MART-1 genes code for antigens that are specifically recognized by cytolytic T lymphocytes in a MHC-restricted manner. The MAGE-1 and MAGE-3 genes are expressed in tumors of different histotypes but not in normal adult tissues (with the exception of testis), while the MART-1 gene appears to be selectively expressed in melanoma. MAGE-1, MAGE-3 and MART-1 antigens may therefore constitute useful targets for specific anti-tumor immunization of cancer patients. Here we have investigated the expression of MAGE-1, MAGE-3 and MART-1 in 11 neuroblastoma (NB) cell lines and 73 NB tumor masses. MAGE-1 and MAGE-3 transcripts were detected simultaneously in 36% of the cell lines and in 16% of tumor samples. The MAGE-1 gene was never expressed alone except in one tumor. In contrast, MAGE-3 mRNA was found in approximately 40% of the NB tumor samples in the absence of MAGE-1 mRNA. No expression of the MART-1 gene was observed in any cell line or tumor sample. No correlation was found between MAGE gene expression and clinical stage, event-free survival and presence or absence of N-myc amplification.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Neoplasm,
http://linkedlifedata.com/resource/pubmed/chemical/MAGEA1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/MAGEA3 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/MART-1 Antigen,
http://linkedlifedata.com/resource/pubmed/chemical/MLANA protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Melanoma-Specific Antigens,
http://linkedlifedata.com/resource/pubmed/chemical/Neoplasm Proteins
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0020-7136
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
21
|
pubmed:volume |
69
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
403-7
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:8900375-Antigens, Neoplasm,
pubmed-meshheading:8900375-Cell Division,
pubmed-meshheading:8900375-Disease-Free Survival,
pubmed-meshheading:8900375-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:8900375-Humans,
pubmed-meshheading:8900375-MART-1 Antigen,
pubmed-meshheading:8900375-Melanoma-Specific Antigens,
pubmed-meshheading:8900375-Neoplasm Proteins,
pubmed-meshheading:8900375-Neuroblastoma,
pubmed-meshheading:8900375-Polymerase Chain Reaction,
pubmed-meshheading:8900375-Tumor Cells, Cultured
|
pubmed:year |
1996
|
pubmed:articleTitle |
Expression of MAGE-1, MAGE-3 and MART-1 genes in neuroblastoma.
|
pubmed:affiliation |
Laboratory of Oncology, G. Gaslini Children's Hospital, Genoa, Italy.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|